Fifth Third Bancorp
FBRX icon

Fifth Third Bancorp’s Forte Biosciences FBRX Stock Holding History

Fifth Third Bancorp’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
+496
New +$14.3K ﹤0.01% 3632

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Fifth Third Bancorp's FBRX Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Forte Biosciences (FBRX) in Q1 2026: 496 shares worth $12.8K. The stake represents ﹤0.01% of the portfolio and ranks #3632 among its holdings.

68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Fifth Third Bancorp held 496 shares of Forte Biosciences worth $12.8K as of Q1 2026.
  • Forte Biosciences was a new Fifth Third Bancorp position in Q1 2026.
  • Forte Biosciences made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3632 holding.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.